Intravenous haloperidol treatment of severely regressed, nonviolent psychiatric inpatients.
The use of intravenous haloperidol in five severely regressed, nonviolent, psychiatric inpatients with psychotic disorders is described. Unlike previous reports in the consultation psychiatry literature, this treatment was not instituted to control combative behavior in the medically ill. All patients had intravenous access in place for hydration. Four of five patients were discharged in complete remission of psychotic symptoms after brief hospitalizations. The indications for use, dosages, and general absence of side effects are described. Intravenous haloperidol is a viable option for treating severely ill psychiatric inpatients with psychotic disorders.
Plotnick
E K
EK
Department of Psychiatry, Wilford Hall Medical Center, San Antonio, Texas.
Brown
G R
GR
D000328:Adult; D006220:Haloperidol / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006778:Hospitals, Psychiatric; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy*; D012043:Regression, Psychology
D006220:Haloperidol